ALPS Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,436
| Closed | -$151K | – | 1036 |
|
|
2025
Q1 | $151K | Sell |
44,436
-3,874
| -8% | -$13.1K | ﹤0.01% | 971 |
|
|
2024
Q4 | $199K | Buy |
+48,310
| New | +$199K | ﹤0.01% | 973 |
|
|
2016
Q2 | – | Sell |
-157
| Closed | -$142K | – | 624 |
|
|
2016
Q1 | $142K | Sell |
157
-27
| -15% | -$24.4K | ﹤0.01% | 613 |
|
|
2015
Q4 | $259K | Sell |
184
-33
| -15% | -$46.5K | ﹤0.01% | 660 |
|
|
2015
Q3 | $3.63K | Buy |
217
+80
| +58% | +$1.34K | ﹤0.01% | 638 |
|
|
2015
Q2 | $296K | Buy |
+137
| New | +$296K | ﹤0.01% | 656 |
|